Broad and DuPont yield CRISPR licensing deal in agriculture
19-10-2017
Although the Patent Trial and Appeal Board (PTAB) gave a win to The Broad Institute of Harvard and MIT in the CRISPR patent conflict against the University of California (UC), Berkeley and the University of Vienna, lawyers say the dispute may still not be resolved.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
UC Berkeley, CRISPR, PTAB, The Broad Institute, Harvard, MIT, genome editing, CRISPR-Cas9, Federal Circuit, patent
